Early alert on this stock. Volume is all right, just looking for a price action. The chart pattern is good.
MNOV: MediciNova, Inc. 2022-06-08 06:30:00 MediciNova Announces Positive Top-Line Results from Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute Respiratory Distress Syndrome
The company's stock is in the consolidation stage strongly The stock is now buy I do not recommend Stop Loss because you will be taken out by the market makers I cannot say more details about my strategy as it is very confidential
MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan through our joint development with MediciNova, we will proceed with further non-clinical and clinical trial development as quickly as possible globally and not only in Japan. We are confident that the BC-PIV SARS-CoV-2 vaccine will be successful and hope that this...
Contextual immersion trading strategy idea. The demand for shares of MediciNova looks higher than the supply. The company focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs. Due to the spread of COVID-19, the demand for the company`s services rose. This and other conditions can cause a...
Bearish until bullish, chart looks strong. Upon break of CTL (counter trend line) look for Long opportunities.
Float 29M 24M CASH NO DEBT NEWS
relative strength good macd about to cross cci and percent r good above 50 ma cmf going up j hook pattern biotech long base
With all the participant in ICE-BUCKET challenge around the globe, ALS.org did a tremendous job on started this movement in raising the awareness of Amyotrophic Lateral Sclerosis. MNOV took the opportunity and initiate clinical trial on ALS. Stock momentum is picking up, chart is currently showing bullish sign.
Consolidation with small volume and held above 200 day SMA. 20 and 50 SMA cross in play.
Huge gap up, which led to a poor close. Did break $4.70 resistance and stayed above 200 day SMA. May be a good time to buy.
Huge gap up, which led to a poor close. Did break $4.70 resistance and stayed above 200 day SMA. May be a good time to buy.
Huge gap up, which led to a poor close. Did break $4.70 resistance and stayed above 200 day SMA. May be a good time to buy.
Huge gap up, which led to a poor close. Still stayed above 200 day SMA. Also has SMA crosses in play. May be a good time to buy.